Updates in Oncology
MedicineWorld.Org brings updates in the field of oncology that you cannot afford to miss. This page is meant to keep you updated on the latest events in the world of cancer. This updates in oncology covers the most relevent developments in the field of oncology and is expected to be a useful reference for physicians and patients.
| MedicineWorld.Org: Updates in oncology |
Breast cancer
Taxotere plus Herceptin improves survival (July 15, 2005)
Letrozole superior to Tamoxifen in adjuvant setting (June 16, 2005)
Herceptin Chemotherapy combination Improves survival in early stage breast cancer (April 25, 2005)
Avastin plus Chemotherapy Improves Survival for Breast Cancer (April 17, 2005)
Zometa reduces risk of skeletal complications (April 8, 2005)
New options in HER-2 positive breast cancer patients (March 30, 2005)
FDA approves Abraxane for the treatment of metastatic breast cancer (Jan 9, 2005)
Arimidex better than tamoxifen in the adjuvant treatment of breast cancer (Dec 8, 2004)
Lung cancer
Treatment options for advanced non-small cell lung cancer (June 12, 2005)
Clinical Trial of Iressa (Gefitinib) for Lung Cancer halted early (April 18, 2005)
Avastin in combination with chemotherapy improves survival in lung cancer (March 15, 2005)
Iressa fails to show survival advantage (Dec 18, 2004)
Tarceva approved for the tratment of NSCLC Nov 19, 2004
FDA approves Alimta for the second line treatment of NSCLC
Important information on Alimta
Colorectal cancer
Test to determine camptosar dose Dec 20, 2005
Oxaliplatin plus Avastin improves survival: ECOG study Nov 29, 2004
Bevacizumab plus IFL improves survival in metastatic colorectal cancer (June 3, 2004)
Prostate cancer
Provenge significantly improves survival in advanced prostate cancer (Feb 17, 2005)
Carcinoid tumors
Slow Release Octreotide Increases survival in Carcinoid Syndrome (April 29, 2005)
Renal cell cancer
FDA apporves Sorafenib for metastatci renal cell cancer (Dec 20, 2005)
Sorafenib doubles survival in renal cell cancer (July 21, 2005)
Multiple myeloma
New alerts for Velcade (Bortezomib) (June 16, 2005)
Bortezomib (valcade) approved for second line treatment of myeloma (March 25, 2005)
CML
Drug interactions for imatinib (Feb 8, 2006)
New options for patients with CML (June 15, 2005)
Head and neck cancer
Erbitux plus Radiation effective in Head and Neck Cancer (June 9, 2005)
Pancreatic cancer
FDA Approves New Drug Combination For Pancreatic Cancer (November 8, 2005)
Capecitabine Gemzar Combination Improves Survival For Pancreatic Cancer (November 21, 2005)
Advances in pancreatic cancer (July 21, 2005)
Tarceva significantly improves survival in advanced pancreatic cancer (March 24, 2005)
| MedicineWorl.Org: Updates in oncology |
Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.
|
|
